{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:22:41Z","timestamp":1792678961849,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"am","delay-in-days":238,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.accpm.2023.101193","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:38:41Z","timestamp":1672922321000},"page":"101193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multimodal strategy to counteract vasodilation in septic shock"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-758X","authenticated-orcid":false,"given":"Marc","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Depret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0049-6248","authenticated-orcid":false,"given":"Ines","family":"Lakbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-163X","authenticated-orcid":false,"given":"Sheila Nainan","family":"Myatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2023.101193_bib0005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00134-022-06883-y","article-title":"Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis","volume":"48","author":"De Pascale","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0015","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/cc6814","article-title":"Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock","volume":"12","author":"Kumar","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0020","article-title":"Therapeutic strategies for high-dose vasopressor-dependent shock","volume":"2013","author":"Bassi","year":"2013","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.accpm.2023.101193_bib0025","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s00134-019-05770-3","article-title":"Less is more: catecholamine-sparing strategies in septic shock","volume":"45","author":"Venkatesh","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00134-018-5242-5","article-title":"A global perspective on vasoactive agents in shock","volume":"44","author":"Annane","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.accpm.2023.101193_bib0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000005344","article-title":"Early multimodal vasopressors\u2014are we ready for it?","volume":"50","author":"Wieruszewski","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0065","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.accpm.2023.101193_bib0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","article-title":"Esmolol to treat the hemodynamic effects of septic shock: a randomized controlled trial","volume":"57","author":"Cocchi","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.accpm.2023.101193_bib0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13054-020-03115-x","article-title":"The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial","volume":"24","author":"Cioccari","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0080","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/CCM.0000000000003520","article-title":"The effect of propofol and dexmedetomidine sedation on norepinephrine requirements in septic shock patients: a crossover trial","volume":"47","author":"Morelli","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1067\/mcp.2000.109354","article-title":"Effect of hydrocortisone on phenylephrine\u2014mean arterial pressure dose\u2013response relationship in septic shock","volume":"68","author":"Bellissant","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.accpm.2023.101193_bib0090","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0095","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001932","article-title":"Selepressin in septic shock","volume":"57","author":"Antonucci","year":"2022","journal-title":"Shock (Augusta, Ga)"},{"key":"10.1016\/j.accpm.2023.101193_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13105-013-0280-5","article-title":"Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria","volume":"70","author":"Eyenga","year":"2014","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.accpm.2023.101193_bib0105","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/cells11101598","article-title":"Regulation of oxidative phosphorylation of liver mitochondria in sepsis","volume":"11","author":"Eyenga","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.accpm.2023.101193_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5985209","article-title":"Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies","volume":"2017","author":"Mantzarlis","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.accpm.2023.101193_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","article-title":"Endothelial responses in sepsis","volume":"202","author":"Joffre","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00000539-200001000-00021","article-title":"Nitric oxide and septic vascular dysfunction","volume":"90","author":"Murray","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2023.101193_bib0125","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000105118.66983.19","volume":"32","author":"Bakker","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0140","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1378\/chest.121.6.2000","article-title":"Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence","volume":"121","author":"Michard","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.accpm.2023.101193_bib0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/CCM.0b013e31827bfc25","article-title":"Role of the venous return in critical illness and shock: part II-shock and mechanical ventilation","volume":"41","author":"Funk","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","article-title":"Equilibrating SSC guidelines with individualized care","volume":"25","author":"Vincent","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0155","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","article-title":"Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum","volume":"42","author":"Andreis","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00134-005-2688-z","article-title":"Hemodynamic variables related to outcome in septic shock","volume":"31","author":"Varpula","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0165","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00134-018-5218-5","article-title":"The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients","volume":"44","author":"Maheshwari","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0170","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00134-009-1427-2","article-title":"Arterial blood pressure during early sepsis and outcome","volume":"35","author":"D\u00fcnser","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0175","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0180","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0185","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.CCM.0000063045.77339.B6","article-title":"Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?","volume":"31","author":"De Backer","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association between US norepinephrine shortage and mortality among patients with septic shock","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2023.101193_bib0195","article-title":"Vasopressors for hypotensive shock","volume":"2","author":"Gamper","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.accpm.2023.101193_bib0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc2945","article-title":"Clinical review: vasopressin and terlipressin in septic shock patients","volume":"9","author":"Delmas","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0205","doi-asserted-by":"crossref","first-page":"d194","DOI":"10.2741\/A274","article-title":"Vasopressin signaling pathways in vascular smooth muscle","volume":"3","author":"Nemenoff","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.accpm.2023.101193_bib0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(25)21784-0","article-title":"Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors","volume":"229","author":"Cooper","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.accpm.2023.101193_bib0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1113\/jphysiol.1993.sp019870","article-title":"The influence of vasopressin on the arterioles and venules of skeletal muscle of the rat during systemic hypoxia","volume":"470","author":"Marshall","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.accpm.2023.101193_bib0220","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/cc10453","article-title":"Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock","volume":"15","author":"Morelli","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0225","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00000542-200509000-00014","article-title":"Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits","volume":"103","author":"Faivre","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2023.101193_bib0235","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study","volume":"33","author":"Alban\u00e8se","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1983.sp014803","article-title":"The effect of vasopressin on renal blood flow and its distribution in the rat","volume":"341","author":"Azzawi","year":"1983","journal-title":"J Physiol"},{"key":"10.1016\/j.accpm.2023.101193_bib0245","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.accpm.2023.101193_bib0250","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/01.CCM.0000139708.10718.E3","article-title":"Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits","volume":"32","author":"Albert","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.accpm.2023.101193_bib0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2217\/fca-2020-0019","article-title":"Roles of angiotensin II as vasopressor in vasodilatory shock","volume":"16","author":"Lumlertgul","year":"2020","journal-title":"Future Cardiol"},{"key":"10.1016\/j.accpm.2023.101193_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-018-1995-z","article-title":"Angiotensin in critical care","volume":"22","author":"Hall","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0270","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11626-013-9707-0","article-title":"LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells","volume":"50","author":"Hermanns","year":"2014","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.accpm.2023.101193_bib0275","first-page":"23","article-title":"Effects of E. coli endotoxin on rat plasma angiotensin converting enzyme activity in vitro and in vivo","volume":"21","author":"Deitz","year":"1987","journal-title":"Circ Shock"},{"key":"10.1016\/j.accpm.2023.101193_bib0280","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/thx.40.10.774","article-title":"Angiotensin converting enzyme and endotoxin induced lung damage in the mouse","volume":"40","author":"Cookson","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.accpm.2023.101193_bib0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1378\/chest.91.1.52","article-title":"Angiotensin converting enzyme in bronchoalveolar lavage in ARDS","volume":"91","author":"Idell","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.accpm.2023.101193_bib0290","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients: a prospective observational study","volume":"23","author":"Le\u015bnik","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.accpm.2023.101193_bib0295","first-page":"3","article-title":"The plasma kallikrein\/kinin and renin angiotensin systems in blood pressure regulation in sepsis","volume":"10","author":"Shariat-Madar","year":"2004","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.accpm.2023.101193_bib0300","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.3390\/ph13110347","article-title":"Role of kinins in hypertension and heart failure","volume":"13","author":"Hamid","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.accpm.2023.101193_bib0305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0162-3109(98)00038-1","article-title":"Endogenous B1 receptor mediated hypotension produced by contact system activation in the presence of endotoxemia","volume":"40","author":"Schmid","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.accpm.2023.101193_bib0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0315","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13181-013-0298-7","article-title":"Methylene blue for distributive shock: a potential new use of an old antidote","volume":"9","author":"Jang","year":"2013","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.accpm.2023.101193_bib0320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcrc.2020.02.011","article-title":"Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock","volume":"57","author":"Tchen","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0325","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene Blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0330","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41598-020-58828-4","article-title":"Methylene blue administration in patients with refractory distributive shock \u2014 a retrospective study","volume":"10","author":"Porizka","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.accpm.2023.101193_bib0335","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01706481","article-title":"Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations","volume":"18","author":"Schneider","year":"1992","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0340","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/BF01700666","article-title":"Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock","volume":"21","author":"Gachot","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0883-9441(98)90001-6","article-title":"Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange","volume":"13","author":"Andresen","year":"1998","journal-title":"J Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0350","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003246-199502000-00010","article-title":"Methylene blue administration in septic shock: a clinical trial","volume":"23","author":"Preiser","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0355","article-title":"Efficacy and safety of methylene blue in patients with vasodilatory shock: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.accpm.2023.101193_bib0360","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s12325-020-01422-x","article-title":"Vasopressor-sparing action of methylene Blue in severe sepsis and shock: a narrative review","volume":"37","author":"Puntillo","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.accpm.2023.101193_bib0365","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028599","article-title":"Effect of methylene blue on hemodynamic and metabolic response in septic shock patients","volume":"101","author":"Luis-Silva","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.accpm.2023.101193_bib0370","doi-asserted-by":"crossref","first-page":"12409","DOI":"10.1038\/s41598-017-12635-6","article-title":"Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation","volume":"7","author":"Ahn","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.accpm.2023.101193_bib0375","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjp.0701397","article-title":"Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery","volume":"122","author":"Noguera","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.accpm.2023.101193_bib0380","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/01.CCM.0000206466.56669.BE","article-title":"Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions","volume":"34","author":"Leone","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0385","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1097\/01.CCM.0000186759.13325.DC","article-title":"Marked synergism between vasopressin and angiotensin II in a human isolated artery","volume":"33","author":"Hidaka","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0390","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/jpet.102.047647","article-title":"Alpha 2-adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats","volume":"305","author":"Gao","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.accpm.2023.101193_bib0395","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2478781","article-title":"\u03b1 2-adrenoceptors: challenges and opportunities-enlightenment from the kidney","volume":"2020","author":"Pettinger","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.accpm.2023.101193_bib0400","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2023.101193_bib0405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13054-016-1208-6","article-title":"Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients, from the 36th International symposium on intensive care and emergency medicine : Brussels, Belgium. 15\u201318 March 2016","volume":"20","author":"Oliveira","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0410","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Serpa Neto","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0415","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2023.101193_bib0420","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2023.101193_bib0425","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2023.101193_bib0430","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00134-018-05514-9","article-title":"Preliminary results of synergy between norepinephrine and terlipressin during septic shock","volume":"45","author":"Duclos","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0435","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.ccm.0000510024.07609.07","article-title":"Norepinephrine and vasopressin vs norepinephrine alone for septic shock: randomized controlled trial","volume":"44","author":"Clem","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0440","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5005\/jp-journals-10071-24231","article-title":"Comparison of norepinephrine and terlipressin vs norepinephrine alone for management of septic shock: a randomized control study","volume":"26","author":"Sahoo","year":"2022","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0445","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0450","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SHK.0000000000001978","article-title":"Early initiation of vasopressin reduces organ failure and mortality in septic shock","volume":"58","author":"Rydz","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.accpm.2023.101193_bib0455","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajem.2021.05.007","article-title":"The effect of early vasopressin use on patients with septic shock: a systematic review and meta-analysis","volume":"48","author":"Huang","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0460","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(09)60176-8","article-title":"Clinical efficacy and safety of terlipressin administration in cirrhotic patients with septic shock","volume":"50","author":"Acevedo","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.accpm.2023.101193_bib0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0885066618818460","article-title":"Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin","volume":"35","author":"Rodriguez","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0470","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0475","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.accpm.2023.101193_bib0480","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0485","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.CCM.0000104209.07273.FC","article-title":"Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)","volume":"32","author":"Watson","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0495","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CCM.0000000000005157","article-title":"Renin kinetics and mortality\u2014same, same but different?","volume":"50","author":"Khanna","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0500","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0505","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2023.101193_bib0510","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.accpm.2023.101193_bib0515","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2023.101193_bib0520","first-page":"114","article-title":"Uso de vasopresina en pacientes con choque s\u00e9ptico refractario a catecolaminas","volume":"13","author":"Fonseca-Ruiz","year":"2013","journal-title":"Acta Colombiana de Cuidado Intensivo"},{"key":"10.1016\/j.accpm.2023.101193_bib0525","first-page":"15","article-title":"the therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation. Is it the black box?","volume":"54","author":"Barzegar","year":"2016","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.accpm.2023.101193_bib0530","first-page":"111","article-title":"Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial","volume":"29","author":"Chen","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.accpm.2023.101193_bib0535","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/phar.2105","article-title":"Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock","volume":"38","author":"Hammond","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.accpm.2023.101193_bib0540","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/0886022X.2022.2095286","article-title":"Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study","volume":"44","author":"Wang","year":"2022","journal-title":"Ren Fail"}],"container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556823000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556823000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:50:24Z","timestamp":1762480224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556823000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2352556823000012"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2023.101193","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal strategy to counteract vasodilation in septic shock","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2023.101193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101193"}}